D-0326-2017 Class III Terminated
FDA drug recall D-0326-2017 was initiated by Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals on Dec 22, 2016 and is designated Class III. Reason for recall: Failed Stability Specifications The recall status is terminated (terminated Sep 18, 2017). Affected quantity: 1200 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 11, 2017
- Initiation Date
- Dec 22, 2016
- Termination Date
- Sep 18, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1200 bottles
Product description
TEMAZEPAM CAPSULES USP, 7.5 mg, 100 count bottles, Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC 0603-5891-21
Reason for recall
Failed Stability Specifications
Distribution pattern
Nationwide
Code information
T248H15A, Exp. 08/17
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0326-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026